FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080568049> ?p ?o ?g. }

• W2080568049 endingPage "14354" @default.
• W2080568049 startingPage "14351" @default.
• W2080568049 abstract "The carboxyl-terminal Src kinase (Csk) is an indispensable negative regulator for the Src family tyrosine kinases (SFKs) that play pivotal roles in various cell signalings. To understand the molecular basis of the Csk-mediated regulation of SFKs, we elucidated the crystal structure of full-length Csk. The Csk crystal consists of six molecules classified as active or inactive states according to the coordinations of catalytic residues. Csk assembles the SH2 and SH3 domains differently from inactive SFKs, and their binding pockets are oriented outward enabling the intermolecular interaction. In active molecules, the SH2-kinase and SH2-SH3 linkers are tightly stuck to the N-lobe of the kinase domain to stabilize the active conformation, and there is a direct linkage between the SH2 and the kinase domains. In inactive molecules, the SH2 domains are rotated destroying the linkage to the kinase domain. Cross-correlation matrices for the active molecules reveal that the SH2 domain and the N-lobe of the kinase domain move as a unit. These observations suggest that Csk can be regulated through coupling of the SH2 and kinase domains and that Csk provides a novel built-in activation mechanism for cytoplasmic tyrosine kinases. The carboxyl-terminal Src kinase (Csk) is an indispensable negative regulator for the Src family tyrosine kinases (SFKs) that play pivotal roles in various cell signalings. To understand the molecular basis of the Csk-mediated regulation of SFKs, we elucidated the crystal structure of full-length Csk. The Csk crystal consists of six molecules classified as active or inactive states according to the coordinations of catalytic residues. Csk assembles the SH2 and SH3 domains differently from inactive SFKs, and their binding pockets are oriented outward enabling the intermolecular interaction. In active molecules, the SH2-kinase and SH2-SH3 linkers are tightly stuck to the N-lobe of the kinase domain to stabilize the active conformation, and there is a direct linkage between the SH2 and the kinase domains. In inactive molecules, the SH2 domains are rotated destroying the linkage to the kinase domain. Cross-correlation matrices for the active molecules reveal that the SH2 domain and the N-lobe of the kinase domain move as a unit. These observations suggest that Csk can be regulated through coupling of the SH2 and kinase domains and that Csk provides a novel built-in activation mechanism for cytoplasmic tyrosine kinases. The Src family tyrosine kinases (SFKs), 1The abbreviations used are: SFKSrc family tyrosine kinasePTKprotein tyrosine kinase benign relatives of the oncogenic v-src gene product, are non-receptor types of protein tyrosine kinases (PTKs) that are associated with the plasma membrane through their fatty acylated N termini (1.Brown M.T. Cooper J.A. Biochim. Biophys. Acta. 1996; 1287: 121-149Crossref PubMed Scopus (1086) Google Scholar). The SFKs serve as molecular switches involved in the initiation of a variety of cellular events in the multicellular animals, including cell growth and division, cell attachment and movement, differentiation, survival, and death (2.Thomas S.M. Brugge J.S. Annu. Rev. Cell Dev. Biol. 1997; 13: 513-609Crossref PubMed Scopus (2175) Google Scholar). The SFKs are ordinarily present in an inactive state in which the phosphorylated C-terminal regulatory tyrosine binds to its own SH2 domain (3.Xu W. Harrison S.C. Eck M.J. Nature. 1997; 385: 595-602Crossref PubMed Scopus (1252) Google Scholar). In response to an external stimulus, an SFK becomes activated through dephosphorylation of the C-terminal tyrosine or through binding to another protein that displaces the intramolecular interaction. The phosphorylation of the regulatory tyrosine of SFK is strictly controlled by another PTK, the C-terminal Src kinase (Csk) (4.Nada S. Okada M. MacAuley A. Cooper J.A. Nakagawa H. Nature. 1991; 351: 69-72Crossref PubMed Scopus (511) Google Scholar,5.Nada S. Yagi T. Takeda H. Tokunaga T. Nakagawa H. Ikawa Y. Okada M. Aizawa S. Cell. 1993; 73: 1125-1135Abstract Full Text PDF PubMed Scopus (364) Google Scholar). The loss-of-function of Csk leads to constitutive activation of SFKs, accompanied by severe defects in embryonic development (5.Nada S. Yagi T. Takeda H. Tokunaga T. Nakagawa H. Ikawa Y. Okada M. Aizawa S. Cell. 1993; 73: 1125-1135Abstract Full Text PDF PubMed Scopus (364) Google Scholar). In contrast, gain-of-function of Csk can readily down-regulate SFK-mediated cell signaling (6.Chow L.M. Fournel M. Davidson D. Veillette A. Nature. 1993; 365: 156-160Crossref PubMed Scopus (237) Google Scholar). Therefore, to understand the function and regulation of SFKs, it is essential to clarify the regulation mechanism controlling the phosphorylation of the critical C-terminal tyrosine. Src family tyrosine kinase protein tyrosine kinase Csk is a cytoplasmic PTK consisting of an SH3, an SH2, and a kinase domain (4.Nada S. Okada M. MacAuley A. Cooper J.A. Nakagawa H. Nature. 1991; 351: 69-72Crossref PubMed Scopus (511) Google Scholar). Because it lacks an N-terminal acylation signal, an autophosphorylation site, and a C-terminal regulatory tyrosine, all of which are conserved among SFKs, the regulatory mechanism of Csk appears to be quite different from those of SFKs. The molecular basis of Csk regulation has so far been studied using mutated molecules and isolated domains (7.Sabe H. Hata A. Okada M. Nakagawa H. Hanafusa H. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 3984-3988Crossref PubMed Scopus (213) Google Scholar, 8.Shekhtman A. Ghose R. Wang D. Cole P.A. Cowburn D. J. Mol. Biol. 2001; 314: 129-138Crossref PubMed Scopus (28) Google Scholar). However, lack of the entire structure of Csk has hampered the evaluation of their physiological roles. Some evidence suggests that the SH2 and/or SH3 domain of Csk is essential for SFK regulation (7.Sabe H. Hata A. Okada M. Nakagawa H. Hanafusa H. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 3984-3988Crossref PubMed Scopus (213) Google Scholar, 9.Cloutier J.F. Chow J.M. Veillette A. Mol. Cell. Biol. 1995; 15: 5937-5944Crossref PubMed Scopus (57) Google Scholar) and that recruitment to the membrane is required for Csk function (6.Chow L.M. Fournel M. Davidson D. Veillette A. Nature. 1993; 365: 156-160Crossref PubMed Scopus (237) Google Scholar, 10.Howell B.W. Cooper J.A. Mol. Cell. Biol. 1994; 14: 5402-5411Crossref PubMed Scopus (123) Google Scholar). In this context, we and others have recently identified a membrane phosphoprotein that can tightly bind to the SH2 domain of Csk (Cbp or PAG) (11.Kawabuchi M. Satomi Y. Takao T. Shimonishi Y. Nada S. Nagai K. Tarakhovsky A. Okada M. Nature. 2000; 404: 999-1003Crossref PubMed Scopus (464) Google Scholar, 12.Brdicka T. Pavlistova D. Leo A. Bruyns E. Korinek V. Angelisova P. Scherer J. Shevchenko A. Hilgert I. Cerny J. Drbal K. Kuramitsu Y. Kornacker B. Horejsi V. Schraven B. J. Exp. Med. 2000; 191: 1591-1604Crossref PubMed Scopus (406) Google Scholar). Upon phosphorylation, Cbp/PAG can recruit Csk to a membrane microdomain, so-called lipid Rafts, to terminate SFK signaling. More recently, we found that the binding to the phosphorylated Cbp/PAG could directly activate Csk (13.Takeuchi S. Takayama Y. Ogawa A. Tamura K. Okada M. J. Biol. Chem. 2000; 275: 29183-29186Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). Thus it is likely that Cbp/PAG plays an important role in Csk regulation. On the other hand, other proteins that could functionally bind to the SH2 domain of Csk, such as Paxillin and FAK, have been identified previously (7.Sabe H. Hata A. Okada M. Nakagawa H. Hanafusa H. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 3984-3988Crossref PubMed Scopus (213) Google Scholar). These findings suggest that Csk is regulated through its SH2 domain in vivo, although the molecular basis of this regulation remains thoroughly unknown. To address this issue, we here elucidated the entire structure of Csk by crystallographic analysis. The full-length (amino acids 1–450) rat Csk was expressed using baculovirus vector in insect cells and purified essentially by the same methods as described previously (13.Takeuchi S. Takayama Y. Ogawa A. Tamura K. Okada M. J. Biol. Chem. 2000; 275: 29183-29186Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar), except that β-octyl-d-glucoside was added (instead of Nonidet P-40) to the buffer during chromatography processes and that the final gel filtration chromatography was performed in a buffer consisting of 100 mm Tris-HCl (pH 8.5), 150 mm NaCl, 5 mm β-mercaptoethanol, 1 mm EDTA, 5% glycerol, and 0.02% β-octyl-d-glucoside. Size estimation was carried out on a Superdex200 HR10/30 column equilibrated with phosphate-buffered saline. Sedimentation equilibrium was performed by ultracentrifugation at 17,000 rpm for 22 h. Concentration distributions were measured using the Rayleigh interference optics. The purified Csk was concentrated to ∼12 mg/ml, mixed with 50 mm Hepes-NaOH (pH 7.4) containing 1.90–1.95 m ammonium sulfate, and crystallized in a sitting drop by vapor diffusion at 288 K for 1–2 months. All data were collected at the cryogenic temperature (around 100 K) using 25% (v/v) ethylene glycol as a cryoprotectant. The native1, native2, and Hg data were collected on the PX210 (Oxford) at BL44XU, Quantum4 (adsc) at BL40B2, and on the marCCD (Mar research) at BL41XU in SPring-8, respectively. The diffraction images were reduced and scaled with Mosflm (ccp4 (14.Collaborative Computing Project 4Acta Crystallogr. Sect. D Biol. Crystallogr. 1994; 50: 760-763Crossref PubMed Scopus (19797) Google Scholar)) and Scala (ccp4) in native1 and Denzo/Scalepack (15.Otwinowski Z. Minor W. Methods Enzymol. 1997; 276: 307-326Crossref PubMed Scopus (38617) Google Scholar) in native2 and Hg data sets. The intensities were converted to the structure factor amplitudes with TRUNCATE (ccp4). Subsequent phasing calculations were performed using native2 and Hg data. The six Hg positions were first located using SHELXS-97 (16.Sheldrick G. Methods Enzymol. 1997; 276: 628-641Crossref PubMed Scopus (129) Google Scholar), followed by the minor site specification, heavy atom parameter refinement, and the SIRAS phase calculation with SHARP (17.de La Fortelle E. Bricogne G. Methods Enzymol. 1997; 276: 472-494Crossref PubMed Scopus (1797) Google Scholar). The density modification with SOLOMON (ccp4) permitted us clear interpretation of the electron density map. The atomic model was built using O (18.Jones T.A. Zou J.Y. Cowan S.W. Kjeldgaard M. Acta Crystallogr. Sect. A. 1991; 47: 110-119Crossref PubMed Scopus (13014) Google Scholar) and refined with the native1 data set using CNS (19.Brünger A.T. Adams P.D. Clore G.M. DeLano W.L. Gros P. Grosse-Kunstleve R.W. Jiang J.S. Kuszewski J. Nilges M. Pannu N.S. Read R.J. Rice L.M. Simonson T. Warren G.L. Acta Crystallogr. Sect. D Biol. Crystallogr. 1998; 54: 905-921Crossref PubMed Scopus (16979) Google Scholar). Of the 2,298 non-glycine and non-proline residues, 83.0% fell into the most favored regions, 16.1% into the additional allowed regions, 0.9% into the generously allowed regions, and no residue into the disallowed regions of Ramachandran plot as defined in PROCHECK. Coordinates have been deposited with the Protein Data Bank under accession codes 1K9A. The full-length rat Csk was produced using a baculovirus vector in insect cells and purified through sequential column chromatography. Although Csk from the brain tissue (<0.01 mg/ml) behaved as a monomer (50 kDa) on gel filtration chromatography (20.Okada M. Nakagawa H. J. Biol. Chem. 1989; 264: 20886-20893Abstract Full Text PDF PubMed Google Scholar), the highly concentrated Csk from insect cells (>1 mg/ml) was eluted with an apparent molecular size around 100 kDa (data not shown). Sedimentation equilibrium analysis also revealed that Csk is present as a dimer at concentrations around 1 mg/ml (data not shown). These findings demonstrate that Csk tends to dimerize at high protein concentrations in vitro. The crystal structure of Csk was solved by the heavy atom single isomorphous replacement method. Crystallographic data and refinement statistics are shown in Table I. An interesting feature of Csk crystal is that it consists of six molecules divided into three pairs of putative dimers per asymmetric unit. This is probably because of oligomerization of Csk dimers during crystallization processes. The dimers are made with loose interactions through the backside of the kinase domains and the SH3 domains. Two of the six molecules, in distinct dimers, make further contact with each other and appear to have some distortions in their structures as described later. In every molecule, however, the three functional domains, SH2, SH3, and kinase, are arranged in a similar manner with the SH2 and SH3 domains diametrically opposite on the top of the N-lobe of the kinase domain (Fig. 1, A and C). Although the position of the SH3 domain resembles the position of the SH3 domain of inactive forms of SFKs, the position of the SH2 domain is entirely different (3.Xu W. Harrison S.C. Eck M.J. Nature. 1997; 385: 595-602Crossref PubMed Scopus (1252) Google Scholar). In addition, there is no direct contact between the SH2 and SH3 domains of Csk.Table ISummery of crystallographic data and refinement statisticsNative1Native2CH3HgBrSpace groupP212121Cell parameters a (Å)115.0115.0115.1 b (Å)162.6162.6162.9 c(Å)232.4232.4232.5Wavelength (Å)0.9001.0001.007Resolution range1-aValues in parentheses are for the last resolution shell.(Å)73–2.5 (2.64–2.50)30–2.6 (2.69–2.60)49–2.9 (3.0–2.9)Number of unique reflections1-aValues in parentheses are for the last resolution shell.150,489 (17,029)136,322 (13,573)93,131 (9,172)Completeness1-aValues in parentheses are for the last resolution shell.98.2 (98.2)99.4 (99.9)99.9 (98.8)Multiplicity1-aValues in parentheses are for the last resolution shell.5.0 (4.5)5.2 (4.9)5.9 (5.1)I/ς1-aValues in parentheses are for the last resolution shell.6.9 (1.7)8.812.1R sym1-aValues in parentheses are for the last resolution shell.(%)7.3 (39.8)5.9 (39.0)6.9 (36.2)R cryst/R free(%)24.6/28.8Root mean square deviationBond lengths (Å)0.007Bond angles (°)1.4271-a Values in parentheses are for the last resolution shell. Open table in a new tab The SH3 domains fold canonically with two anti-parallel sheets of five β-strands sandwiched into a compact structure. There are virtually no differences from the structure of an isolated Csk-SH3 domain (21.Borchert T.V. Mathieu M. Zeelen J.P. Courtneidge S.A. Wierenga R.K. FEBS Lett. 1994; 341: 79-85Crossref PubMed Scopus (61) Google Scholar) except that the N-terminal region is disordered in the isolated SH3 domain (Fig. 1 A). The peptide-binding pocket of the SH3 domain is oriented outward (Fig. 1 C) enabling the intermolecular interaction, and the interactions between the SH3 and SH2-kinase linker observed in inactive SFK structures are absent. The SH2 domains are also canonical, consisting of a central β-sheet flanked by two α-helices as in c-Src (Fig. 1 A), although an insertion is present in the loop region of the c-Src SH2 domain. However, a significant difference can be observed in the orientations of the SH2 domains when all six Csk molecules are superimposed (Fig. 1 B). In four Csk molecules, the ligand binding surfaces face to the left in Fig. 1 B, whereas those of the other two are rotated upward ∼60° (Fig. 1 B). This disorientation may reflect an unusual flexibility of the SH3-SH2 linker and SH2-kinase linker, which form a hinge about which the SH2 domain pivots. These two linkers make extensive hydrophobic contacts with the N-lobe of the kinase domain (Fig. 1 A and Fig. 3). In the SH2-kinase linker, there is an α-helix, which is designated as αBC, that is absent from SFKs (Fig. 1 A). All the hydrophobic residues involved in engaging the SH2 and kinase domains are highly conserved among Csks derived from various species, suggesting that docking of the SH2 linkers into the kinase domain is important for regulation. The kinase domains of the four Csk molecules whose SH2 domains face to the leftin Fig. 1 B can be readily superimposed on the kinase domain of an active SFK, Lck (22.Yamaguchi H. Hendrickson W.A. Nature. 1996; 384: 484-489Crossref PubMed Scopus (423) Google Scholar). The positions of residues crucial for catalytic activity (Asp-314, Asn-319, and Asp-332) and the critical ion bridge that orients the γ-phosphate of ATP (Glu-236 in αC and Lys-222 in β3) are consistent with those of Lck (Fig. 2, A and B). All these features suggest that the four molecules are most likely to be enzymatically active. The active site similarity with Lck is rather remarkable considering that Csk differs from SFKs in its activation loop (Fig. 2, red). The activation loop of Csk (331–348) is four residues shorter than and diverged from that of Lck, and, critically, it lacks a phosphorylated tyrosine residue (Fig. 2 E). In addition, Csk residues are either substantially displaced as compared with their counterparts in Lck (338–342, 346–349) or disordered (343–345). In SFKs, autophosphorylation of the activation loop tyrosine is regulatory and essential for full catalytic activity and for transforming potential (23.Gonfloni S. Weijland A. Kretzschmar J. Superti-Furga G. Nat. Struct. Biol. 2000; 7: 281-286Crossref PubMed Scopus (92) Google Scholar, 24.Sun G. Ramdas L. Wang W. Vinci J. McMurray J. Budde R.J. Arch Biochem. Biophys. 2002; 397: 11-17Crossref PubMed Scopus (36) Google Scholar). In Lck, this phosphotyrosine (Tyr-394) is essential to coordinate Arg-363 and Arg-387 and thus stabilize the active structure. In Csk, however, the side chain of Lys-337, which corresponds to Arg-387 in Lck, has no apparent coordinations to a specific partner, yet the main chain lies within 1.5 Å of Lck Arg-337 when the C-lobes are superimposed. The similarity in active sites despite the absence of phosphate in the activation loop suggests that another mechanism maintains the active conformation of Csk. Previously it has been reported that deletion of sequences preceding the kinase domain significantly reduces Csk activity (7.Sabe H. Hata A. Okada M. Nakagawa H. Hanafusa H. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 3984-3988Crossref PubMed Scopus (213) Google Scholar, 8.Shekhtman A. Ghose R. Wang D. Cole P.A. Cowburn D. J. Mol. Biol. 2001; 314: 129-138Crossref PubMed Scopus (28) Google Scholar, 25.Sondhi D. Cole P.A. Biochemistry. 1999; 38: 11147-11155Crossref PubMed Scopus (61) Google Scholar, 26.Sun G. Budde R.J. Arch. Biochem. Biophys. 1999; 367: 167-172Crossref PubMed Scopus (29) Google Scholar), and a role of the SH3-SH2 linker in Csk activation has been suggested (8.Shekhtman A. Ghose R. Wang D. Cole P.A. Cowburn D. J. Mol. Biol. 2001; 314: 129-138Crossref PubMed Scopus (28) Google Scholar). In a structure of the isolated kinase domain bound to staurosporine, the helix αC is kinked and flexible, destroying the critical salt bridge between Lys-222 and Glu-236 (Fig. 2 D) (27.Lamers M.B. Antson A.A. Hubbard R.E. Scott R.K. Williams D.H. J. Mol. Biol. 1999; 285: 713-725Crossref PubMed Scopus (138) Google Scholar). In the case of Lck, however, an isolated kinase domain retains full activity (28.Zhu X. Kim J.L. Newcomb J.R. Rose P.E. Stover D.R. Toledo L.M. Zao H. Morqenstern K.A. Structure Fold Des. 1999; 7: 651-661Abstract Full Text Full Text PDF Scopus (253) Google Scholar). As already mentioned, in Csk there are tight interactions between the two linkers and the N-lobe of the kinase domain. Notably, the helix αC, which positions Glu-236, is oriented by extensive contacts with the linkers (Fig. 3). This resembles the case of CDK2 that is partially activated through binding to cyclin A (29.Jeffrey P.D. Russo A.A. Polyak K. Gibbs E. Hurwitz J. Massaque J. Pavletich N.P. Nature. 1995; 376: 313-320Crossref PubMed Scopus (1216) Google Scholar). The binding of cyclin A to the helix αC (containing PSTAIRE motif) of CDK2 induces a dramatic change in the orientation of the helix αC so that the catalytic residues are appropriately coordinated for the catalysis. Therefore, instead of the activating phosphotyrosine, Csk may require the interaction between the kinase domain and the linkers to stabilize the active conformation. In contrast with the active molecules, the two Csk molecules with rotated SH2 domains appear to be inactive. These molecules are substantially different from the active molecules in the backbone carbon positions of the N-lobe of the kinase domain (Fig. 1 B). Importantly, the critical ion pair (between Glu-236 and Lys-222) is absent (Fig. 2 C) although the conformation of the catalytic domain is apparently different from that of the isolated kinase domain bound to staurosporine (27.Lamers M.B. Antson A.A. Hubbard R.E. Scott R.K. Williams D.H. J. Mol. Biol. 1999; 285: 713-725Crossref PubMed Scopus (138) Google Scholar). Furthermore, there is a major difference between the active and inactive molecules in the SH2-kinase interface (Fig. 3); the interactions between the βD-βE loop of the SH2 domain and β3-αC loop in the N-lobe of kinase domain are absent in the inactive molecules. These indicate that rotation of the SH2 domain could affect the conformation of the N-lobe of the kinase domain, implicating the functional relationship between the SH2 domain and the kinase domain. To address the above issue, we calculated cross-correlation matrices for the deviations of the backbone carbon atoms of the molecules in the crystal. The cross-correlation matrix was recently found to be useful to assess interdomain interactions in molecular dynamics studies (30.Young M.A. Gonfloni S. Superti-Furga G. Roux B. Kuriyan J. Cell. 2001; 105: 115-126Abstract Full Text Full Text PDF PubMed Scopus (344) Google Scholar). Fortunately, our crystal contained multiple copies of Csk molecules in an asymmetric unit, and we used four crystallographically independent copies instead of conformational snapshots in the molecular dynamics study. The C-lobes of the kinase domains were first superimposed by the program LSQKAB (14.Collaborative Computing Project 4Acta Crystallogr. Sect. D Biol. Crystallogr. 1994; 50: 760-763Crossref PubMed Scopus (19797) Google Scholar), and then we generated a set of averaged positions of the α carbon. The correlation between two atoms can be defined using the deviations from their respective average positions. It is obvious that the correlation value for two atoms in the same domain shows an absolute value close to 1 as the domain moves en bloc. If two residues move independently, the correlation will be near 0. It is usually observed that the correlation between two atoms in the “superimposed” region is flattened to 0. As shown in Fig. 4, for four active-state molecules, clusters of positive correlations between two atoms lie in the regions indicating correlations between the SH2 domain and β1-β2 and β3-αC regions of the kinase domain. This indicates that these segments deviate en bloc in the crystal, representing a functional coupling between the SH2 and the kinase domain. The structure of Csk presented here highlights the functional interactions of the catalytic domain with the SH2 domain and its linkers and suggests a novel activation mechanism that is distinct from the phosphorylation-dependent regulation of SFKs. The presence of an inactive conformation of Csk, which is probably produced by the unusual flexibility of the hinge region of the SH2 domain, also suggests that there may be a dynamic equilibrium between active and inactive Csk. It is known that a strong ligand of the SH2 domain, the phosphorylated Cbp/PAG, could elicit potentially full activity of Csk (13.Takeuchi S. Takayama Y. Ogawa A. Tamura K. Okada M. J. Biol. Chem. 2000; 275: 29183-29186Abstract Full Text Full Text PDF PubMed Scopus (133) Google Scholar). Therefore, it is probable that binding of Cbp/PAG ligand to the SH2 domain could fix the active state to make the kinase constitutively active. It is also possible that the conformation change induced by the SH2 ligand could affect the region responsible for the substrate recognition. To verify these hypotheses, the structural details of Csk association with Cbp/PAG are now under investigation. Among the many types of cytoplasmic protein tyrosine kinases, including the Fes, Abl, Syk, Tec, and Csk families, the SFKs are unusual in that they are negatively regulated by phosphorylation of the C-terminal regulatory site. The SH2 domain of the SFK serves as an acceptor for the phosphorylated regulatory tyrosine. All the aforementioned cytoplasmic tyrosine kinases also possess an SH2 domain adjacent to the catalytic domain but have no C-terminal phosphotyrosine. Although the actual roles of SH2 domains in these enzymes remain to be studied at the molecular level, the structures of Csk presented here could be representative of cytoplasmic tyrosine kinases other than SFKs. We thank J. A. Cooper for discussions and comments on the manuscript, T. Hirose and A. Nagata for production of recombinant Csk in Sf9 cells, N. Ito for aid in matrix presentation, K. Yutani and M. Sakai for sedimentation equilibrium analysis, E. Yamashita for valuable technical comments and suggestions, and beamline staffs at SPring-8 including M. Kawamoto and K. Miura for help in data collection. 1K9A" @default.
• W2080568049 created "2016-06-24" @default.
• W2080568049 creator A5010554991 @default.
• W2080568049 creator A5019076098 @default.
• W2080568049 creator A5030415403 @default.
• W2080568049 creator A5034569226 @default.
• W2080568049 creator A5036244962 @default.
• W2080568049 creator A5036653863 @default.
• W2080568049 creator A5043406290 @default.
• W2080568049 creator A5077422183 @default.
• W2080568049 creator A5080888597 @default.
• W2080568049 date "2002-04-01" @default.
• W2080568049 modified "2023-10-17" @default.
• W2080568049 title "Structure of the Carboxyl-terminal Src Kinase, Csk" @default.
• W2080568049 cites W1521881285 @default.
• W2080568049 cites W1539796472 @default.
• W2080568049 cites W1548078808 @default.
• W2080568049 cites W1549736588 @default.
• W2080568049 cites W1591680814 @default.
• W2080568049 cites W1700519873 @default.
• W2080568049 cites W1881522644 @default.
• W2080568049 cites W1967897783 @default.
• W2080568049 cites W1969939692 @default.
• W2080568049 cites W1970973812 @default.
• W2080568049 cites W1981660923 @default.
• W2080568049 cites W1991683855 @default.
• W2080568049 cites W1995017064 @default.
• W2080568049 cites W2001641653 @default.
• W2080568049 cites W2003229373 @default.
• W2080568049 cites W2013083986 @default.
• W2080568049 cites W2019293169 @default.
• W2080568049 cites W2025170327 @default.
• W2080568049 cites W2033444434 @default.
• W2080568049 cites W2034152669 @default.
• W2080568049 cites W2064812124 @default.
• W2080568049 cites W2073300307 @default.
• W2080568049 cites W2089827156 @default.
• W2080568049 cites W2090389694 @default.
• W2080568049 cites W2095372350 @default.
• W2080568049 cites W2101257013 @default.
• W2080568049 cites W2102256105 @default.
• W2080568049 cites W2160675888 @default.
• W2080568049 cites W2167305208 @default.
• W2080568049 doi "https://doi.org/10.1074/jbc.c200086200" @default.
• W2080568049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11884384" @default.
• W2080568049 hasPublicationYear "2002" @default.
• W2080568049 type Work @default.
• W2080568049 sameAs 2080568049 @default.
• W2080568049 citedByCount "143" @default.
• W2080568049 countsByYear W20805680492012 @default.
• W2080568049 countsByYear W20805680492013 @default.
• W2080568049 countsByYear W20805680492014 @default.
• W2080568049 countsByYear W20805680492015 @default.
• W2080568049 countsByYear W20805680492016 @default.
• W2080568049 countsByYear W20805680492017 @default.
• W2080568049 countsByYear W20805680492018 @default.
• W2080568049 countsByYear W20805680492019 @default.
• W2080568049 countsByYear W20805680492020 @default.
• W2080568049 countsByYear W20805680492021 @default.
• W2080568049 countsByYear W20805680492022 @default.
• W2080568049 countsByYear W20805680492023 @default.
• W2080568049 crossrefType "journal-article" @default.
• W2080568049 hasAuthorship W2080568049A5010554991 @default.
• W2080568049 hasAuthorship W2080568049A5019076098 @default.
• W2080568049 hasAuthorship W2080568049A5030415403 @default.
• W2080568049 hasAuthorship W2080568049A5034569226 @default.
• W2080568049 hasAuthorship W2080568049A5036244962 @default.
• W2080568049 hasAuthorship W2080568049A5036653863 @default.
• W2080568049 hasAuthorship W2080568049A5043406290 @default.
• W2080568049 hasAuthorship W2080568049A5077422183 @default.
• W2080568049 hasAuthorship W2080568049A5080888597 @default.
• W2080568049 hasBestOaLocation W20805680491 @default.
• W2080568049 hasConcept C108636557 @default.
• W2080568049 hasConcept C183141693 @default.
• W2080568049 hasConcept C184235292 @default.
• W2080568049 hasConcept C185592680 @default.
• W2080568049 hasConcept C196347352 @default.
• W2080568049 hasConcept C2779664074 @default.
• W2080568049 hasConcept C31258907 @default.
• W2080568049 hasConcept C41008148 @default.
• W2080568049 hasConcept C55493867 @default.
• W2080568049 hasConcept C86803240 @default.
• W2080568049 hasConcept C95444343 @default.
• W2080568049 hasConceptScore W2080568049C108636557 @default.
• W2080568049 hasConceptScore W2080568049C183141693 @default.
• W2080568049 hasConceptScore W2080568049C184235292 @default.
• W2080568049 hasConceptScore W2080568049C185592680 @default.
• W2080568049 hasConceptScore W2080568049C196347352 @default.
• W2080568049 hasConceptScore W2080568049C2779664074 @default.
• W2080568049 hasConceptScore W2080568049C31258907 @default.
• W2080568049 hasConceptScore W2080568049C41008148 @default.
• W2080568049 hasConceptScore W2080568049C55493867 @default.
• W2080568049 hasConceptScore W2080568049C86803240 @default.
• W2080568049 hasConceptScore W2080568049C95444343 @default.
• W2080568049 hasIssue "17" @default.
• W2080568049 hasLocation W20805680491 @default.
• W2080568049 hasLocation W20805680492 @default.
• W2080568049 hasOpenAccess W2080568049 @default.

• next